[How transparent is the new Dutch guideline on cardiovascular risk management?]
Clicks: 206
ID: 42008
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
206 views
27 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #28 of 47 articles by views in nederlands tijdschrift voor geneeskunde
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The new Dutch guideline on cardiovascular risk management has lowered the target value for LDL cholesterol from 2.5 to 1.8 mmol/L. The authors claim transparency, yet there is no hard scientific evidence that supports this new target value. There is only a theoretical model developed by theCholesterol Treatment Trialists' (CTT) Collaboration Group. This group has the raw data of the cholesterol trials and they have signed confidentiality agreements with manufacturers stating that they will not share this data with others. This group also produced the Cochrane review on primary cardiovascular prevention with statins. If the real effect of cholesterol-lowering drugs is not disclosed to the population in a transparent manner, this will be done through independent channels with the message 'leave those PCSK9 inhibitors alone until there is hard scientific evidence for their efficacy.' And if patients suffer greatly from, for example,muscle pain, diabetes or amnesia due to taking statins, in accordance with the guideline they will decide for themselves whether or not to continue taking it.
| Reference Key |
bijl2019hownederlands
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bijl, Dick; |
| Journal | nederlands tijdschrift voor geneeskunde |
| Year | 2019 |
| DOI |
D4334
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.